Prevention of postoperative venous thrombosis. A randomized trial comparing low-dose heparin and low molecular weight heparin in gynaecological oncology;Low-Dose-Heparin versus niedermolekulares Heparin zur Thromboseprophylaxe in der operativen gynakologischen Onkologie

Geburtshilfe und Frauenheilkunde

Volumn 57, Issue 1, 1997, Pages 1-6

  Heilmann, L ^a,c   Von Tempelhoff, G F ^a   Herrle, B ^a   Hojnacki, B ^a   Schneider, D ^a   Michaelis, H Ch ^a   Wolf, H ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Sandoz AG   (Germany)

^c Gesundheits und Pflegezentrum Russelsheim   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GYNECOLOGIC CANCER; HUMAN; IMPEDANCE PLETHYSMOGRAPHY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; VEIN THROMBOSIS;

EID: 0031046835     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1023030     Document Type: Article

References (31)

1. Becker, S. C., V. T. Miller: Heparin induced thrombocytopenia, Stroke 20 (1989) 1449-1459.
2. Bergqvist, D., B. Lindblad: A 30 year survey of pulmonary embolism verified at autopsy: an analysis of 1274 surgical patients. Brit. J. Surg. 72 (1985) 105-108.
3. Bergqvist, D.: Prophylaxis of postoperative venous thromboembolism. In Nyhus, L.M.: Surgery Annual. Appleton & Lange (1986).
4. Blum, A., E. Desruenes, A. Elias, G. Lagrange, J. F. Loriferne: TVT prophylaxis in surgery for digestive tract cancer comparing the LME heparinoid ORG 10172 (Lomoparan) with calcium heparin. Thromb & Haemost 62 (1989) 126.
5. Clagett, G. P., J. S. Reisch: Prevention of venous thromboembolism in general surgical patients. An. Surg. 208 (1988) 227-240.
6. Clarke-Pearson, D. L., E. DeLong, I. S. Synan, J. T. Soper, W. T. Creasman, R. E. Colemann: A controlled trial of two low-dose-heparin regimes for the prevention of postoperative deep vein thrombosis. Obstet GynecoL 75 (1990) 683-689.
7. Clarke-Pearson, D. L., I. S. Synan, W. M. Hinshaw, R. E. Colemann, W. T. Creasman: The prevention of postoperative venous thromboembolism by external pneumatic calf compression in patients with gynecologic malignancy. Obst Gynecol. 63 (1984) 92-98.
8. Clarke-Pearson, D. L., R. E. Colemann, I. S. Synan, W. M. Hinshaw, W. T. Creasman: Venous thromboembolism prophylaxis in gynecologic oncology: A prospective controlled trial of low dose heparin. Am. J. Obstet Gynecol. 145 (1983) 606-613.
9. Collins, R., A. Scrimgeour, S. Yusuf, R. Peto: Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. New Engl. J. Med. 318 (1988) 1162-1173.
10. Crandon, A. J., K. R. Peel, J. A. Anderson, V. Thompson, G. P. McNicol: Prophylaxis of postoperative deep vein thrombosis: Selective use of low dose heparin in high risk patients. Brit. Med. J. I (1980) 345-347.
11. Encke, A., K. Breddin: Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. Brit. J. Surg. 75 (1988) 1058-1063.
12. Fricker, J.-P., Y. Vergnes, R. Schach, A. Heitz, M. Eber, I., Grunebaum, M.-L. Wiesel, A. Kher, P. Barbier, J.-P. Casenave: Low dose heparin versus low molecular weigth heparin (Kabi 2165, Fragmin) in the prophylaxis of thromboembolic complications of abdominal oncological surgery. Europ. J. Clin. Invest. 18 (1988) 561-567.
13. Gallus, A., J. Cade, P. Ockelford, S. Hepburn, M. Maas, H. Magnani, T. Bucknall, J. Stevens, F. Porteous: Orgaran (ORG 10172) or heparin for preventing venous thrombosis after elective surgery for malignant disease? A double-blind randomised multicentre comparison. Thromb. & Haemost. 70 (1993) 562-567.
14. Godwin, J. E., P. Comp., B. Davidson, M. Rossi: Comparison of the efficacy and safety of subcutaneous RD Heparin vs subcutaneous unfractionated heparin for the prevention of deep-vein thrombosis in patients undergoing abdominal or pelvic surgery for cancer. Thromb. & Haemost. 69 (1993) 647.
15. Gordon-Smith, I. C., D. J. Grundy, L. P. Le Quesne, J. F. Newcombe, F. J. Bramble: Controlled trial of two regimens of subcutaneous heparin in prevention of postoperative deep-vein thrombosis. Lancet I (1972) 1133-1135.
16. Hohl, M. K, K. P. Lüscher, J. Tichy, M. Stiner, R. Fridrich, U. F. Gruber, O. Käser: Prevention of postoperative thromboembolism by Dextran 70 or low dose heparin. Obstet. Gynecol. 55 (1980) 497-500.
17. Kakkar, V. V., A. T. Cohen, R. A. Edmonson, M. J. Philips, D. J. Cooper, S. K. Das, K. T. Maher, R. M. Sanderson, V. P. Ward, S. Kakkar: Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. Lancet 341 (1993) 251-265.
18. Kakkar, V. V., T. P. Corrigan, D. P. Fossard: Prevention and management of venous thrombosis. Brit. Med. Bull. 50 (1994) 871-903.
19. Kakkar, V. V., T. P. Corrigan, D. P. Fossard: Prevention of fatal postoperative pulmonary embolism by low doses of heparin. Lancet I (1975) 45-54.
20. Kakkar, V. V., T. P. Corrigan, J. Spindler, D. P. Fossard, P. T. Flute, R. Q. Crellin, S. Wessler, E. T. Yin: Efficacy of low doses of heparin in prevention of deep vein thrombosis after major surgery. Lancet I (1972) 101-106.
21. Kakkar, V. V., W. J. G. Murray: Efficacy and safety of low molecular-weight heparin (CY 216) in preventing postoperative venous thromboembolism: a co-operative study. Brit J. Surg. 72 (1985) 786-791.
22. Leizorovicz, A., M. C. Haugh, F. R. Chapuis, M. M. Samama, J.-P. Boisel: Low molecular heparin in prevention of perioperative thrombosis. Brit. J. Med. 305 (1992) 913-920.
23. Levine, M. N.: Cancer patients. In Goldhaber, S. Z.: Prevention of venous thromboembolism. Marcel Dekker Inc. New York, Basel, Hongkong (1993).
24. McCarthy, T. G., J. McQueen, F. D. Johnstone, J. Weston, S. Campbell: A comparison of low-dose subcutaneous heparin and intravenous Dextran 70 in the prophylaxis of deep venous thrombosis after gynaecological surgery. J. Obstet. Gynecol. Brit. Cwlth. 81 (1974) 486-491.
25. McLeod, R., W. Geerts, K. Sniderman, C. Greenwood, R. Gregoire, B. Taylor, R. Silverman, K. Atkinson, M. Burnstein, J. Marshall, C. Burul, D. Anderson, T. Ross, S. Wilson, P. Barton: Thromboprophylaxis in colorectal surgery - A randomised trial comparing low dose heparin and enoxparin. Thromb. & Haemost. 73 (1995) 979.
26. Miller, B., L. Heilmann: Hemorheological parameters in patients with gynecologic malignancies. Gynecol. Oncol. 33 (1989) 177-181.
27. Rickles, F. R., M. Levine, R. L. Edwards: Hemostatic alterations in cancer patients. Cancer and Metastasis Reviews 11 (1992) 237-248.
28. Tempelhoff, G.-F. von, L. Heilmann: Thrombosis and hemorheology in patients with breast cancer and adjuvant chemotherapy. Clin. Hemorheology 15 (1995) 311-323.
29. Walsh, J. J., J. Bonnar, F. W. Wright: A study of pulmonary embolism and deep leg vein thrombosis after major gynecological surgery using labelled fibrinogen - phlebography and lung scanning. J. Obstet. Cynecol. Brit. Cwlth. 81 (1974) 311-316.
30. Warkentin, T., J. G. Kelton: Interaction of heparin with platelets, including heparin induced thrombocytopenia. In Bounameaux, H.: Low molecular heparins in prophylaxis and therapy of thromboembolic diseases. Marcel Dekker. Inc., New York, Basel, Hongkong (1994).
31. Wheeler, H. B., F. A. Anderson: Diagnostic methods for deep vein thrombosis. Haemostasis 25 (1995) 6-26.